| | | | | | | | | | | | | | | | | | | | | | |
|
|
|
|
| 2004N-0181 - Critical Path Initiative; Establishment of Docket
|
|
|
|
|
|
| FDA Comment Number :
|
| EC18
|
|
|
|
|
|
|
|
|
|
|
| Submitter :
|
| Dr. Jeffrey Lerner
|
| Date & Time:
|
| 08/02/2004 06:08:01
|
|
|
|
|
| Organization :
|
| ECRI
|
|
|
|
|
| Other Organization
|
|
|
| Category :
|
|
|
|
|
| Issue Areas/Comments
|
|
|
|
|
|
| Comment Issues
|
|
|
|
|
|
|
|
| 1. Hurdle Identification. Please describe the product development issue, the nature of the evaluation tool that is out-of-date or absent, how this problem hinders product development, and how a solution would improve the product development process.
|
|
|
|
|
|
|
|
|
|
|
| See general comment in last field.
|
|
|
|
|
|
|
|
| GENERAL
|
|
|
|
|
|
|
|
| GENERAL
|
|
|
|
|
|
|
|
| ECRI is planning to provide detailed comments shortly. We believe this is an important initiative. Our comments will support continuing and enhanced scientific evaluation of products as a key to improved process.
|
|
|
|
|
|
|
|